Lode Debrabandere
2012
In 2012, Lode Debrabandere earned a total compensation of $392.3K as President and CEO at Osiris Therapeutics, a 5% decrease compared to previous year.
Compensation breakdown
| Bonus | $35,000 |
|---|---|
| Option Awards | $65,000 |
| Salary | $292,250 |
| Total | $392,250 |
Debrabandere received $292.3K in salary, accounting for 75% of the total pay in 2012.
Debrabandere also received $35K in bonus and $65K in option awards.
Rankings
In 2012, Lode Debrabandere's compensation ranked 9,441st out of 11,487 executives tracked by ExecPay. In other words, Debrabandere earned more than 17.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,441 out of 11,487 | 18th |
Division Manufacturing | 3,495 out of 4,253 | 18th |
Major group Chemicals And Allied Products | 960 out of 1,198 | 20th |
Industry group Drugs | 719 out of 920 | 22nd |
Industry Biological Products, Except Diagnostic Substances | 128 out of 160 | 20th |
Source: SEC filing on April 30, 2015.
Debrabandere's colleagues
We found three more compensation records of executives who worked with Lode Debrabandere at Osiris Therapeutics in 2012.